ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
HealthCare Global Enterprises held its 28th Annual General Meeting on September 18, 2026, via video conferencing to transact business items listed in the notice.
HealthCare Global Enterprises Limited granted 64,46,843 employee stock options under its ESOS 2026 scheme. The grant carries an exercise price of INR 495 per share.
HCG reported a strong Q1FY27 with 13% YoY revenue growth and 20% EBITDA growth, driven by volume and improved payor mix.
HCG reported strong Q1 FY27 results with 13% YoY revenue growth and 20% Adjusted EBITDA growth. Strategic focus on oncology and capacity expansion through a new North Bengaluru facility.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹693.4 Cr (+13.3% YoY) and net profit of ₹16.5 Cr (+175.0% YoY) for Q1 FY27.
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.
HCG delivered strong FY26 results with 15% revenue growth and margin expansion to 18.5%, driven by operational leverage and clinical excellence.
HCG reported FY26 revenue of INR 25.4bn (up 15% YoY) and Adj. EBITDA of INR 4.7bn (up 19% YoY), driven by network productivity and operational leverage.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹650.3 Cr (+11.5% YoY) and net profit of ₹4 Cr (-41.2% YoY) for Q4 FY26.